Cequent Pharmaceuticals, Inc. Garners $4,500,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e661692a-8cc9-4a3a-bf21-11f3794d2dda&Preview=1 -
Date
2/7/2008 -
Company Name
Cequent Pharmaceuticals, Inc. -
Mailing Address
One Kendall Square, Building 700, First Floor Cambridge, MA 02139 -
Company Description
Cequent Pharmaceuticals, Inc. is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of products to treat gastrointestinal diseases, including familial polyposis, inflammatory bowel disease and colon cancer. -
Website
http://www.cequentpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
